<VariationArchive VariationID="17861" VariationName="NM_000041.4(APOE):c.146del (p.Gly49fs)" VariationType="Deletion" Accession="VCV000017861" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-02" DateCreated="2017-02-17" MostRecentSubmission="2017-02-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32900" VariationID="17861">
      <GeneList>
        <Gene Symbol="APOE" FullName="apolipoprotein E" GeneID="348" HGNC_ID="HGNC:613" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="44905796" stop="44909393" display_start="44905796" display_stop="44909393" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45409038" stop="45412649" display_start="45409038" display_stop="45412649" Strand="+" />
          </Location>
          <OMIM>107741</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000041.4(APOE):c.146del (p.Gly49fs)</Name>
      <CanonicalSPDI>NC_000019.10:44907859:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="44907860" stop="44907860" display_start="44907860" display_stop="44907860" variantLength="1" positionVCF="44907859" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45411117" stop="45411117" display_start="45411117" display_stop="45411117" variantLength="1" positionVCF="45411116" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G49fs</ProteinChange>
      <ProteinChange>G75fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.44907862del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.44907862del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.45411119del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.45411119del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007084.2" sequenceAccession="NG_007084" sequenceVersion="2" change="g.7081del">
            <Expression>NG_007084.2:g.7081del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000041.4" sequenceAccession="NM_000041" sequenceVersion="4" change="c.146del" MANESelect="true">
            <Expression>NM_000041.4:c.146del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000032.1" sequenceAccession="NP_000032" sequenceVersion="1" change="p.Gly49fs">
            <Expression>NP_000032.1:p.Gly49fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302688.2" sequenceAccession="NM_001302688" sequenceVersion="2" change="c.224del">
            <Expression>NM_001302688.2:c.224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289617.1" sequenceAccession="NP_001289617" sequenceVersion="1" change="p.Gly75fs">
            <Expression>NP_001289617.1:p.Gly75fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302689.2" sequenceAccession="NM_001302689" sequenceVersion="2" change="c.146del">
            <Expression>NM_001302689.2:c.146del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289618.1" sequenceAccession="NP_001289618" sequenceVersion="1" change="p.Gly49fs">
            <Expression>NP_001289618.1:p.Gly49fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302690.2" sequenceAccession="NM_001302690" sequenceVersion="2" change="c.146del">
            <Expression>NM_001302690.2:c.146del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289619.1" sequenceAccession="NP_001289619" sequenceVersion="1" change="p.Gly49fs">
            <Expression>NP_001289619.1:p.Gly49fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302691.2" sequenceAccession="NM_001302691" sequenceVersion="2" change="c.146del">
            <Expression>NM_001302691.2:c.146del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001289620.1" sequenceAccession="NP_001289620" sequenceVersion="1" change="p.Gly49fs">
            <Expression>NP_001289620.1:p.Gly49fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2122132718" DB="dbSNP" />
        <XRef Type="Allelic variant" ID="107741.0017" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000041.4(APOE):c.146del (p.Gly49fs) AND Familial type 3 hyperlipoproteinemia" Accession="RCV000019444" Version="25">
        <ClassifiedConditionList TraitSetID="5895">
          <ClassifiedCondition DB="MedGen" ID="C0020479">Familial type 3 hyperlipoproteinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-02-17" MostRecentSubmission="2017-02-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1360898</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5895" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12902" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type 3</ElementValue>
                <XRef ID="MONDO:0018473" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysbetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial dysbetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Broad beta disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Remnant removal disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial type 3 hyperlipoproteinemia</ElementValue>
                <XRef ID="398796005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Broad-betalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Apolipoprotein e, deficiency or defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysbetalipoproteinemia due to defect in apolipoprotein e-d</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hyperbeta- and prebetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia with hyperlipemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Floating-betalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipemia with familial hypercholesterolemic xanthomatosis</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6703" />
                <XRef ID="6703" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ES, 2012">
                <ID Source="PubMed">22962670</ID>
                <ID Source="pmc">3431581</ID>
              </Citation>
              <XRef ID="412" DB="Orphanet" />
              <XRef ID="C0020479" DB="MedGen" />
              <XRef ID="MONDO:0018473" DB="MONDO" />
              <XRef Type="MIM" ID="617347" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39734" SubmissionDate="2017-02-14" DateLastUpdated="2017-02-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107741.0017_HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY, AUTOSOMAL RECESSIVE" title="APOE, 1-BP DEL, 2919G_HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000039734" DateUpdated="2017-02-17" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Feussner et al. (1992) identified in German subjects with autosomal recessive familial dysbetalipoproteinemia (617347) a 1-bp deletion (G) at the last nucleotide of codon 30 at position 2919 of exon 3 (or the first 2 nucleotides of codon 31 at nucleotide positions 2920 or 2921). This frameshift mutation (called APOE0) creates a termination at codon 60 resulting in a truncated protein. Individuals heterozygous for this mutation display reduced plasma apolipoprotein E levels. Subjects homozygous for this allele have undetectable plasma apolipoprotein E levels concomitant with severe forms of familial dysbetalipoproteinemia.</Attribute>
              <Citation>
                <ID Source="PubMed">1360898</ID>
              </Citation>
              <XRef DB="OMIM" ID="617347" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOE" />
          </GeneList>
          <Name>APOE, 1-BP DEL, 2919G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2919G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107741.0017" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39734" TraitType="Disease" MappingType="Name" MappingValue="HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C0020479" Name="Familial type 3 hyperlipoproteinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

